Halozyme
HALO
110 hedge funds and large institutions have $861M invested in Halozyme in 2013 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 40 increasing their positions, 33 reducing their positions, and 16 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
43% more capital invested
Capital invested by funds: $603M → $861M (+$258M)
21% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 33
19% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 16
11% more call options, than puts
Call options by funds: $8.89M | Put options by funds: $8M
0% more funds holding
Funds holding: 110 → 110 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$9.38M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$6.12M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.89M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$3.87M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$1.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$3.56M |
| 2 |
Barclays
London,
United Kingdom
|
-$3.35M |
| 3 |
TL
Tirschwell & Loewy
New York
|
-$3.15M |
| 4 |
UBS AM
Chicago,
Illinois
|
-$2.55M |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$1.19M |
HALO Hedge Fund Activity: Q3 2013 in Review
110 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q3 2013, worth a combined $861M — up 43% from $603M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new HALO positions and 16 closed out — a net gain of 3 holders — while 40 added to existing stakes and 33 trimmed.
The largest buyer was Sectoral Asset Management, adding an estimated $9.38M. The largest seller was Citadel Advisors, cutting an estimated $3.56M.
- 110 institutional investors held Halozyme (HALO) as of Q3 2013, unchanged from Q2 2013.
- Funds reported $861M of Halozyme stock for Q3 2013, up 43% quarter-over-quarter.
- 19 funds opened new Halozyme positions in Q3 2013 and 16 closed out, a net change of +3 holders.
- The largest Halozyme buyer in Q3 2013 was Sectoral Asset Management, an estimated $9.38M added.
- The largest Halozyme seller in Q3 2013 was Citadel Advisors, an estimated $3.56M sold.
Based on aggregated 13F filings for Q3 2013.